Biosimilars Industry Celebrates EMA’s Plan to Reduce Clinical Trials

Paper On Streamlining Development Wins Plaudits At Medicines for Europe Conference

Biosimilars are heading for a more streamlined path to market in Europe (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Geography